- Home
- EMF
as 11-21-2024 4:00pm EST
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as financials, consumer staples, industrials, telecommunication, insurance, Entertainment, banks, and others.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 201.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 29.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $10.58 - $12.67 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Templeton Emerging Markets Fund News
EMF Breaking Stock News: Dive into EMF Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Franklin Templeton Closed-End Funds Announce Share Repurchases for the Third Quarter of 2024
Business Wire
4 months ago
Franklin Templeton Closed-End Funds Announce Share Repurchases for the Second Quarter of 2024
Business Wire
7 months ago
Franklin Templeton Closed-End Funds Announce Share Repurchases for the First Quarter of 2024
PR Newswire
10 months ago
Rainbow Realty Group Announces Launch of Fund IV: Capitalizing on a Moment in Time
Zacks
10 months ago
2seventy bio (TSVT) Divests R&D Assets to Regeneron, Stock Up
Zacks
10 months ago
Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround
Zacks
10 months ago
Amgen Inc. (AMGN) Soars to 52-Week High, Time to Cash Out?
Zacks
10 months ago
Best Momentum Stocks to Buy for January 24th
Compare EMF vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EMF Templeton Emerging Markets Fund - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.